Open original FDA record ↗Recall record
- FDA identifier
- Z-1839-2019
- Company in FDA record
- GE Healthcare, LLC
- FDA record creation date
- Jun 18, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Overestimation bias in automatically calculated ejection fraction (EF) values while using LVivo EF app on the Vscan Extend product.
Source facts
- Action
- GE Healthcare notified customers on about 05/21/2019 via "URGENT MEDICAL DEVICE CORRECTION" letter. Customers were instructed to discontinue use of the LVivo EF app until a correction is available and installed on the Vscan Extend. However Vscan Extend can continue to be used for all other existing cleared indications including all other Vscan Extend apps and measurements. GE Healthcare will correct all affected products at no cost. When the LVivo EF app update is available through GE Marketplace, customers will receive an email notification sent to the email address they set up during the Vscan Extend device registration process. Questions or concerns regarding the notification can be directed to GE Healthcare Service at 1-800-437-1171 or your local Service Representative.
- Initiated
- 2019-05-21
- Root cause
- Software design
- Distribution
- Worldwide distribution - US nationwide distributed in the states of CA, FL, IL, MA , MD, MI, MN, NY, SC, TX, UT. Countries of Australia, China, Croatia, Czech Republic, Denmark, France, Germany, Greece, Hong Kong, Ireland, Italy, Japan, Korea (Republic Of), Netherlands, Romania, Sweden, Switzerland, Thailand, United Kingdom.
- Recall number
- Z-1839-2019
- Recall status
- Open, Classified
- CDRH record ID
- 173162
- FDA record created
- 2019-06-18
- Recall event number
- 82938